Take Homes from CTOS Annual Meeting

“There are many exciting studies in progress to look forward to” at future Connective Tissue Oncology Society meetings, according to Candace Haddox, MD.

Candace Haddox, MD, explored advances in genetic sequencing for sarcomas, which was a major theme of the Connective Tissue Oncology Society Annual Meeting, in this video interview with Healio.

In this video, Candace Haddox, MD, discussed a few presentations from the Connective Tissue Oncology Society Annual Meeting that focused on how better understanding of sarcoma biology could lead to clinical advancement.

In this video, Chandrajit Raut, MD, MS, discussed results from the first study using a registry trying to “raise the quality of surgery” for retroperitoneal sarcomas, which was presented at the Connective Tissue Oncology Society Annual Meeting.

Chandrajit Raut, MD, MS, talked about a video session at the Connective Tissue Oncology Society Annual Meeting on approaching oncologic surgery for sarcoma specialists.

In a video interview with Healio, Chandrajit Raut, MD, MS, discussed highlights from “one of the best” Connective Tissue Oncology Society meetings he has attended.

Sandra D’Angelo, MD, discussed a clinical trial on trabectedin in combination with low-dose irinotecan in Ewing sarcoma presented at the Connective Tissue Oncology Society Annual Meeting.

Healio spoke with Sandra D’Angelo, MD, about a study of rogaratinib in patients with succinate dehydrogenase-deficient gastrointestinal stromal tumor presented at the Connective Tissue Oncology Society Annual Meeting.

Sandra D’Angelo, MD, talked about a study examining the role of tumor-infiltrating lymphocyte, or TIL, in metastatic sarcoma presented at the Connective Tissue Oncology Society Annual Meeting in a video interview.

In this video, Sandra D’Angelo, MD, discussed a phase 1b study on the efficacy and safety of botensilimab plus balstilimab in patients with refractory metastatic sarcoma presented at the Connective Tissue Oncology Society Annual Meeting.